A Research Study of JNJ-26854165 to Determine the Safety and Dose in Patients With Advanced Stage or Refractory Solid Tumors.
Clinical trial NCT00676910 · COMPLETED
Trial details
- NCT number
- NCT00676910
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.